NeuroQure

Clinical Science Supports Early Autism Risk Detection

The ASD Insight™ test represents a paradigm shift in autism spectrum disorder (ASD) detection, moving from behavioral observation to cellular biomarker identification. Built on eight years of research at UC Irvine's Center for Autism Research and Translation (CART), this breakthrough test identifies autism risk through analysis of intracellular calcium signaling pathways.

A smiling woman and a young boy exploring a small globe together on a playroom floor

Molecular Basis of Autism Detection: IP₃ Receptor–Mediated Calcium Signaling

Current autism diagnosis relies on behavioral assessments that cannot be reliably administered before 18–24 months of age, with a median diagnosis occurring at 5 years. The ASD Insight™ test detects disrupted calcium homeostasis at the cellular level, specifically targeting inositol trisphosphate receptor (IP₃R) dysfunction in the endoplasmic reticulum. This organelle channelopathy manifests as defective calcium release from intracellular stores, creating a detectable biomarker present from birth across multiple autism etiologies, including monogenic syndromes (Fragile X, Tuberous Sclerosis) and idiopathic autism spectrum disorder.

A smiling child with hands on cheeks

Diagnostic Accuracy & Sensitivity Profile

The ASD Insight™ test demonstrates 75% sensitivity in detecting autism risk with specificity optimized to minimize false positives. The performance profile identifies approximately 3 out of 4 children who will develop autism spectrum disorder, providing clinically actionable information years before behavioral symptoms manifest.

Read Our Key Studies

Autism Diagnosis at Birth via Functional Analysis of IP Receptor Ca2+ Signaling Iin Fibroblasts

Discover the latest research from J. Gargus, D. Justus, JS. Dolinsky, J. Limon, E. Chao, and I. Smith of NeuroQure. We aimed to develop a Ca2+ signaling assay that will be adopted as an ASD risk detection test.

High-Throughput Screen Detects Calcium Signaling Dysfunction in Typical Sporadic ASD

A groundbreaking study reveals that individuals with ASD exhibit distinct metabolic profiles. Using advanced metabolomics analysis, researchers identified significant differences in key metabolic pathways, such as amino acid and lipid metabolism. These findings pave the way for innovative diagnostic tools and therapeutic approaches, offering new insights into the biological underpinnings of ASD.

Why Test For ASD Risk?

Know Earlier

By screening at birth, families are able to plan early intervention, enabling access to developmental therapies during critical neuroplasticity windows when intervention efficacy is maximized.

Act Sooner

Published research demonstrates that early intervention beginning before age 2 results in average IQ improvements of 17+ points compared to standard care initiated at typical diagnosis age.

The Power of Early Autism Intervention

The average age of ASD diagnosis is five years old. Early intervention leads to...

  • 41% in life-long services cost savings

  • Apply for qualifying services with traditionally long wait times

  • Plan ahead for living arrangements, schools, insurance, and more

Laboratory / Test Information
Relevant Literature